Viewing Study NCT06704269


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-01-02 @ 11:54 AM
Study NCT ID: NCT06704269
Status: RECRUITING
Last Update Posted: 2025-10-07
First Post: 2024-11-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module